{"id":"https://openalex.org/W3122018306","doi":"https://doi.org/10.1097/inf.0000000000003077","title":"A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients","display_name":"A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients","publication_year":2021,"publication_date":"2021-01-21","ids":{"openalex":"https://openalex.org/W3122018306","doi":"https://doi.org/10.1097/inf.0000000000003077","mag":"3122018306","pmid":"https://pubmed.ncbi.nlm.nih.gov/33480665","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8104010"},"language":"en","primary_location":{"id":"doi:10.1097/inf.0000000000003077","doi":"https://doi.org/10.1097/inf.0000000000003077","is_oa":true,"landing_page_url":"https://doi.org/10.1097/inf.0000000000003077","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/inf.0000000000003077","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114040189","display_name":"Miroslava Bosheva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119774","display_name":"University Multipurpose Hospital for Active Treatment \"Sveti Georgi\"","ror":"https://ror.org/02psj8r24","country_code":"BG","type":"healthcare","lineage":["https://openalex.org/I4210119774"]}],"countries":["BG"],"is_corresponding":true,"raw_author_name":"Miroslava Bosheva","raw_affiliation_strings":["Medical University, University Multiprofile Hospital for Active Treatment \u201cSveti Georgi,\u201d Plovdiv, Clinic of Pediatric and Genetic Diseases, Plovdiv, Bulgaria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University, University Multiprofile Hospital for Active Treatment \u201cSveti Georgi,\u201d Plovdiv, Clinic of Pediatric and Genetic Diseases, Plovdiv, Bulgaria","institution_ids":["https://openalex.org/I4210119774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042914510","display_name":"Rusudan Gujabidze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rusudan Gujabidze","raw_affiliation_strings":["Amtel Hospital First Clinical LLC, Department of Pediatrics, Tbilisi, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amtel Hospital First Clinical LLC, Department of Pediatrics, Tbilisi, Georgia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031978528","display_name":"\u00c9va K\u00e1roly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c9va K\u00e1roly","raw_affiliation_strings":["Department of Pediatrics, Baja, B\u00e1cs-Kiskun, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Baja, B\u00e1cs-Kiskun, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104284649","display_name":"\u00c1gnes N\u00e9meth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Agnes Nemeth","raw_affiliation_strings":["Semmelweis University, Second Department of Pediatrics, Unit of Pulmonology, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University, Second Department of Pediatrics, Unit of Pulmonology, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050156373","display_name":"Mikael Saulay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mikael Saulay","raw_affiliation_strings":["Basilea Pharmaceutica International Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica International Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024008506","display_name":"Jennifer I. Smart","orcid":"https://orcid.org/0000-0002-4310-6599","observed_orcids":["https://orcid.org/0000-0002-4310-6599"]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jennifer I. Smart","raw_affiliation_strings":["Basilea Pharmaceutica International Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica International Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076511543","display_name":"Kamal A. Hamed","orcid":"https://orcid.org/0000-0003-1896-9736","observed_orcids":["https://orcid.org/0000-0003-1896-9736"]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Kamal A. Hamed","raw_affiliation_strings":["Basilea Pharmaceutica International Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica International Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5114040189"],"corresponding_institution_ids":["https://openalex.org/I4210119774"],"apc_list":null,"apc_paid":null,"fwci":1.4395,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.79478753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"40","issue":"6","first_page":"e222","last_page":"e229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.07959999889135361,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftobiprole","display_name":"ceftobiprole","score":1.0},{"id":"https://openalex.org/keywords/childhood-pneumonia","display_name":"pediatric pneumonia","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hospital-acquired-pneumonia","display_name":"nosocomial pneumonia","score":0.953000009059906},{"id":"https://openalex.org/keywords/community-acquired-pneumonia","display_name":"community-acquired pneumonia","score":1.0},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.8450000286102295},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":1.0},{"id":"https://openalex.org/keywords/clinical-cure-rate","display_name":"clinical cure rate","score":0.5870000123977661},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8110737800598145},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.658323347568512},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6103949546813965},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5674013495445251},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.5572220683097839},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5566834211349487},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5004723072052002},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.49516811966896057},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.43713468313217163},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.4169420003890991},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.39471280574798584},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.320050448179245},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.08856883645057678},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003428","descriptor_name":"Cross Infection","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003428","descriptor_name":"Cross Infection","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018410","descriptor_name":"Pneumonia, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/inf.0000000000003077","doi":"https://doi.org/10.1097/inf.0000000000003077","is_oa":true,"landing_page_url":"https://doi.org/10.1097/inf.0000000000003077","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8104010","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8104010","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatr Infect Dis J","raw_type":"Text"},{"id":"pmid:33480665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33480665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Pediatric infectious disease journal","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1097/inf.0000000000003077","doi":"https://doi.org/10.1097/inf.0000000000003077","is_oa":true,"landing_page_url":"https://doi.org/10.1097/inf.0000000000003077","pdf_url":null,"source":{"id":"https://openalex.org/S109369870","display_name":"The Pediatric Infectious Disease Journal","issn_l":"0891-3668","issn":["0891-3668","1532-0987"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Infectious Disease Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1495642555","https://openalex.org/W1595793822","https://openalex.org/W1976231974","https://openalex.org/W1977342232","https://openalex.org/W1990448757","https://openalex.org/W2004207935","https://openalex.org/W2015539970","https://openalex.org/W2022256930","https://openalex.org/W2024175754","https://openalex.org/W2039193912","https://openalex.org/W2042142189","https://openalex.org/W2095034572","https://openalex.org/W2098474364","https://openalex.org/W2107722421","https://openalex.org/W2114034330","https://openalex.org/W2115597546","https://openalex.org/W2116068468","https://openalex.org/W2147634646","https://openalex.org/W2150069228","https://openalex.org/W2162578723","https://openalex.org/W2164552925","https://openalex.org/W2302118651","https://openalex.org/W2319021558","https://openalex.org/W2336143177","https://openalex.org/W2341045795","https://openalex.org/W2410718400","https://openalex.org/W2412389833","https://openalex.org/W2803709395","https://openalex.org/W2809388401","https://openalex.org/W2894320882","https://openalex.org/W2901989937","https://openalex.org/W2912211359","https://openalex.org/W2966369787","https://openalex.org/W3037624378","https://openalex.org/W3084049874","https://openalex.org/W3137421555","https://openalex.org/W6676053923"],"related_works":["https://openalex.org/W2098474364","https://openalex.org/W3200196373","https://openalex.org/W3091144697","https://openalex.org/W2114034330","https://openalex.org/W2171866399","https://openalex.org/W2341045795","https://openalex.org/W2029777400","https://openalex.org/W4393861340","https://openalex.org/W4411600111","https://openalex.org/W7100516824"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"advanced-generation,":[2],"broad-spectrum,":[3],"intravenous":[4],"(IV)":[5],"cephalosporin,":[6],"ceftobiprole,":[7],"is":[8],"an":[9,89],"effective":[10],"and":[11,130,144,152,157,159,178,192,195,205],"well-tolerated":[12],"treatment":[13],"for":[14],"adults":[15],"with":[16,50,70,238],"hospital-acquired":[17],"pneumonia":[18,22],"(HAP)":[19],"or":[20,52,68,71,111,240],"community-acquired":[21],"(CAP),":[23],"but":[24],"its":[25],"effects":[26],"in":[27,126,133,172,189,223,235],"pediatric":[28,236],"patients":[29,43,81,103,156,237],"have":[30],"not":[31],"been":[32],"established.":[33],"METHODS:":[34],"In":[35],"this":[36,224],"multicenter,":[37],"investigator-blinded,":[38],"active-controlled,":[39],"phase":[40,226],"3":[41,44,77,227],"study,":[42,228],"months":[45],"to":[46,59,88,92,106,120,187,214,232],"<18":[47],"years":[48],"old":[49],"HAP":[51,239],"CAP":[53,241],"requiring":[54,242],"hospitalization":[55],"were":[56,104,148,176,203],"randomized":[57,105],"(2:1)":[58],"ceftobiprole":[60,107,128,191],"versus":[61],"standard-of-care":[62],"(SoC)":[63],"IV":[64,79,140],"cephalosporin":[65,114,136],"treatments":[66],"(ceftazidime":[67],"ceftriaxone),":[69],"without":[72],"vancomycin.":[73],"After":[74],"at":[75,169,199],"least":[76],"days'":[78,98],"treatment,":[80],"demonstrating":[82],"clinical":[83,166,196],"improvement":[84],"could":[85],"be":[86],"switched":[87],"oral":[90,121],"antibiotic,":[91],"complete":[93],"a":[94,112],"minimum":[95],"of":[96,154,161],"7":[97],"treatment.":[99],"RESULTS:":[100],"Overall,":[101],"138":[102],"(n":[108,115],"=":[109,116],"94)":[110],"SoC":[113,135,162,233],"44).":[117],"Median":[118],"time":[119],"switch":[122],"was":[123,219],"6.0":[124],"days":[125,132],"the":[127,134,173,190,200],"group":[129],"8.0":[131],"group.":[137],"While":[138],"on":[139],"therapy,":[141],"adverse":[142,146],"events":[143,147],"treatment-related":[145],"reported":[149],"by":[150],"20.2%":[151],"8.5%":[153],"ceftobiprole-treated":[155],"18.2%":[158],"0%":[160],"cephalosporin-treated":[163],"patients.":[164],"Early":[165],"response":[167],"rates":[168,198],"day":[170],"4":[171],"intention-to-treat":[174],"population":[175],"95.7%":[177],"93.2%":[179],"(between-group":[180,207],"difference,":[181,208],"2.6%;":[182],"95%":[183,210],"confidence":[184,211],"interval,":[185,212],"-5.5%":[186],"14.7%)":[188],"comparator":[193],"groups,":[194],"cure":[197],"test-of-cure":[201],"visit":[202],"90.4%":[204],"97.7%":[206],"-7.3%;":[209],"-15.7%":[213],"3.6%),":[215],"respectively.":[216],"CONCLUSIONS:":[217],"Ceftobiprole":[218],"well":[220],"tolerated":[221],"and,":[222],"small":[225],"demonstrated":[229],"similar":[230],"efficacy":[231],"cephalosporins":[234],"hospitalization.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-02-01T00:00:00"}